Exogenous heat shock cognate protein 70 pretreatment attenuates cardiac and hepatic dysfunction with associated anti-inflammatory responses in experimental septic shock

Shock

Volumn 42, Issue 6, 2014, Pages 540-547

  Hsu, Jong Hau ^a,b   Yang, Rei Cheng ^a,b   Lin, Shih Jen ^c   Liou, Shu Fen ^d   Dai, Zen Kong ^a,b   Yeh, Jwu Lai ^c   Wu, Jiunn Ren ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Faculty of Medicine   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Heat shock protein; sepsis; shock

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; CYCLOOXYGENASE 2; GELATINASE B; HEAT SHOCK COGNATE PROTEIN 70; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRATE; NITRIC OXIDE; NITRITE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; HEAT SHOCK PROTEIN 70; MMP9 PROTEIN, RAT; RELA PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HEART DISEASE; HEART PROTECTION; HYPOGLYCEMIA; HYPOTENSION; LIVER DYSFUNCTION; LIVER PROTECTION; MALE; NONHUMAN; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SEPTIC SHOCK; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; ACTIVE TRANSPORT; ANIMAL; BOVINE; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION REGULATION; HEART MUSCLE; HEART VENTRICLE; LIVER; METABOLISM; PATHOPHYSIOLOGY; WISTAR RAT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CATTLE; ENDOTOXEMIA; GENE EXPRESSION REGULATION; HEART VENTRICLES; HSP70 HEAT-SHOCK PROTEINS; LIPOPOLYSACCHARIDES; LIVER; MALE; MATRIX METALLOPROTEINASE 9; MYOCARDIUM; NITRIC OXIDE; RATS; RATS, WISTAR; SHOCK, SEPTIC; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930048155     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000254     Document Type: Article

References (33)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303-1310, 2001.
2. Mayeux PR: Pathobiology of lipopolysaccharide. J Toxicol Environ Health 51(5):415-435, 1997.
3. Angus DC, Birmingham MC, Balk RA, Scannon PJ, Collins D, Kruse JA, Graham DR, Dedhia HR, Homann S, MacIntyre N: for E5 Study Investigators. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. JAMA 283(13):1723-1730, 2000.
4. Angus DC, Wax RS: Epidemiology of sepsis: an update. Crit Care Med 29(7 Suppl):S109-S116, 2001.
5. Kiang JG: Inducible heat shock protein 70 kd and inducible nitric oxide synthase in hemorrhage/resuscitation-induced injury. Cell Res 14(6):450-459, 2004.
6. Giffard RG, Xu L, Zhao H, Carrico W, Ouyang Y, Qiao Y, Sapolsky R, Steinberg G, Hu B, Yenari MA: Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J Exp Biol 207(Pt 18):3213-3220, 2004.
7. Srivastava P: Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2(3):185-194, 2002.
8. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK: HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6(4):435-442, 2000.
9. Gelain DP, de Bittencourt Pasquali MA, Comim MM, Grunwald MS, Ritter C, Tomasi CD, Alves SC, Quevedo J, Dal-Pizzol F, Moreira JC: Serum heat shock protein 70 levels, oxidant status, and mortality in sepsis. Shock 35(5):466-470, 2011.
10. Kimura F, Itoh H, Ambiru S, Shimizu H, Togawa A, Yoshidome H, Ohtsuka M, Shimamura F, Kato A, Nukui Y, Miyazaki M: Circulating heat-shock protein 70 is associated with postoperative infection and organ dysfunction after liver resection. Am J Surg 187(6):777-784, 2004.
11. Genth-Zotz S, Bolger AP, Kalra PR, von Haehling S, Doehner W, Coats AJ, Volk HD, Anker SD: Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int J Cardiol 96(3):397-401, 2003.
12. Kustanova GA, Murashev AN, Karpov VL, Margulis BA, Guzhova IV, Prokhorenko IR, Grachev SV, Evgen'ev MB: Exogenous heat shock protein 70 mediates sepsis manifestations and decreases the mortality rate in rats. Cell Stress Chaperones 11(3):276-286, 2006.
13. Rozhkova E, Yurinskaya M, Zatsepina O, Garbuz D, Karpov V, Surkov S, Murashev A, Ostrov V, Margulis B, Evgen'ev M, et al.: Exogenous mammalian extracellular HSP70 reduces endotoxin manifestations at the cellular and organism levels. Ann N Y Acad Sci 1197:94-107, 2010.
14. Abboud PA, Lahni PM, Page K, Giuliano JS, Harmon K, Dunsmore KE, Wong HR, Wheeler DS: The role of endogenously produced extracellular hsp72 in mononuclear cell reprogramming. Shock 30(3):285-292, 2008.
15. Su X, Sykes JB, Ao L, Raeburn CD, Fullerton DA, Meng X: Extracellular heat shock cognate protein 70 induces cardiac functional tolerance to endotoxin: differential effect on TNF-alpha and ICAM-1 levels in heart tissue. Cytokine 51(1):60-66, 2010.
16. Fernandes CJ Jr, Akamine N, Knobel E: Cardiac troponin: a new serum marker of myocardial injury in sepsis. Intensive Care Med 25(10):1165-1168, 1999.
17. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, Tamayo L, Collado J, Garcia-Labattut A, Carriedo D, Valledor M, et al.: Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 12(6):R158, 2008.
18. Rudiger A, Dyson A, Felsmann K, Carre JE, Taylor V, Hughes S, Clatworthy I, Protti A, Pellerin D, Lemm J, et al.: Early functional and transcriptomic changes in the myocardium predict outcome in a long-term rat model of sepsis. Clin Sci (Lond) 124(6):391-401, 2013.
19. Merx MW, Weber C: Sepsis and the heart. Circulation 116(7):793-802, 2007.
20. Riedemann NC, Guo RF, Ward PA: The enigma of sepsis. J Clin Invest 112(4): 460-467, 2003.
21. Vinokurov M, Ostrov V, Yurinskaya M, Garbuz D, Murashev A, Antonova O, Evgen'ev M: Recombinant human Hsp70 protects against lipoteichoic acid-induced inflammation manifestations at the cellular and organismal levels. Cell Stress Chaperones 17(1):89-101, 2012.
22. Virca GD, Kim SY, Glaser KB, Ulevitch RJ: Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J Biol Chem 264(36): 21951-21956, 1989.
23. Aneja RK, Tsung A, Sjodin H, Gefter JV, Delude RL, Billiar TR, Fink MP: Preconditioning with high mobility group box 1 (HMGB1) induces lipopoly-saccharide (LPS) tolerance. J Leukoc Biol 84(5):1326-1334, 2008.
24. Imamura Y, Wang PL: Salivary histatin 3 inhibits heat shock cognate protein 70Ymediated inflammatory cytokine production through Toll-like receptors in human gingival fibroblasts. J Inflamm (Lond) 11(1):4, 2014.
25. Ayala A, Lomas JL, Grutkoski PS, Chung CS: Pathological aspects of apoptosis in severe sepsis and shock? Int J Biochem Cell Biol 35(1):7-15, 2003.
26. Liu SF, Malik AB: NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 290(4): L622-L645, 2006.
27. Ziegler-Heitbrock HW, Wedel A, Schraut W, Strobel M, Wendelgass P, Sternsdorf T, Bauerle PA, Haas JG, Riethmuller G: Tolerance to lipopolysac-charide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 269(25):17001-17004, 1994.
28. Cowan KJ, Storey KB: Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 206(Pt 7):1107-1115, 2003.
29. Yang SH, Sharrocks AD, Whitmarsh AJ: Transcriptional regulation by the MAP kinase signaling cascades. Gene 320:3-21, 2003.
30. Kim HJ, Lee HS, Chong YH, Kang JL: p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225(1):36-47, 2006.
31. Klintman D, Li X, Santen S, Schramm R, Jeppsson B, Thorlacius H: p38 Mitogen-activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury. Ann Surg 242(6):830-838, discussion 838-839, 2005.
32. Li M, Georgakopoulos D, Lu G, Hester L, Kass DA, Hasday J, Wang Y: p38 MAP kinase mediates inflammatory cytokine induction in cardiomyo-cytes and extracellular matrix remodeling in heart. Circulation 111(19): 2494-2502, 2005.
33. Yang M, Wu J, Martin CM, Kvietys PR, Rui T: Important role of p38 MAP kinase/NF-kappaB signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype. Am J Physiol Heart Circ Physiol 294(2):H994-H1001, 2008.